Beam Therapeutics (BEAM) delivered earnings and revenue surprises of -3.54% and 4%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Castle Biosciences, Inc. (CSTL) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to loss of $0.26 per share a year ...
Bringing a baby home can be one of the most joyful times in a woman’s life, but for many, the experience isn’t always so rosy. Liisa Hantsoo, Ph.D. of the Johns Hopkins Center for Women's Reproductive ...